LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Pancreaticoduodenectomy with right hemicolectomy for advanced malignancy: a single UK hepatopancreaticobiliary centre experience.

    Das, Bibek / Fehervari, Matyas / Hamrang-Yousefi, Sahar / Jiao, Long R / Pai, Madhava / Jenkins, John T / Spalding, Duncan R C

    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

    2022  Volume 25, Issue 1, Page(s) 16–23

    Abstract: Aim: Locally advanced intestinal neoplasms including colon cancer may require radical en bloc pancreaticoduodenectomy and right hemicolectomy (PD-RC) to achieve curative, margin-negative resection, but the safety and benefit of this uncommon procedure ... ...

    Abstract Aim: Locally advanced intestinal neoplasms including colon cancer may require radical en bloc pancreaticoduodenectomy and right hemicolectomy (PD-RC) to achieve curative, margin-negative resection, but the safety and benefit of this uncommon procedure has not been established. The Association of Coloproctology of Great Britain and Ireland IMPACT initiative has also highlighted a lack of awareness about current services available within the UK for patients with advanced colorectal cancer and concerns about low-volume centres managing complex cases. Thus, we aimed to review the feasibility, safety and long-term outcomes of this procedure at a single high-volume hepatopancreaticobiliary surgery unit in the UK.
    Method: A retrospective cohort study was performed using a database of all consecutive patients with intestinal cancer who had been referred to our regional advanced multidisciplinary team and undergone PD-RC in a 7-year period (2013-2020). Clinico-pathological and outcome data were reviewed.
    Results: Ten patients (mean age 54 ± 13, 8/10 men) were identified. Final histology revealed the primary tumour sites were colon (n = 7) and duodenum (n = 3). R0 resection was achieved in all cases. The major complication rate (Clavien-Dindo ≥ 3) was 10% (1/10) with no deaths within 90 days of surgery. The Kaplan-Meier estimated 5-year overall survival was 83.3% (95% CI 58.3%-100%). Univariate survival analysis identified perineural invasion and extra-colonic origin as predictors of poor survival (log-rank P < 0.05).
    Conclusion: En bloc PD-RC for locally advanced intestinal cancer can be performed safely with a high proportion of margin-negative resections and resultant long-term survival in carefully selected patients.
    MeSH term(s) Male ; Humans ; Pancreaticoduodenectomy/methods ; Retrospective Studies ; Colonic Neoplasms/pathology ; Colorectal Neoplasms/surgery ; Colectomy/methods
    Language English
    Publishing date 2022-09-01
    Publishing country England
    Document type Journal Article
    ZDB-ID 1440017-0
    ISSN 1463-1318 ; 1462-8910
    ISSN (online) 1463-1318
    ISSN 1462-8910
    DOI 10.1111/codi.16303
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Dendritic Cells Cross-Present Immunogenic Lentivector-Encoded Antigen from Transduced Cells to Prime Functional T Cell Immunity.

    Hotblack, Alastair / Seshadri, Sara / Zhang, Lei / Hamrang-Yousefi, Sahar / Chakraverty, Ronjon / Escors, David / Bennett, Clare L

    Molecular therapy : the journal of the American Society of Gene Therapy

    2017  Volume 25, Issue 2, Page(s) 504–511

    Abstract: Recombinant lentiviral vectors (LVs) are highly effective vaccination vehicles that elicit protective T cell immunity in disease models. Dendritic cells (DCs) acquire antigen at sites of vaccination and migrate to draining lymph nodes, where they prime ... ...

    Abstract Recombinant lentiviral vectors (LVs) are highly effective vaccination vehicles that elicit protective T cell immunity in disease models. Dendritic cells (DCs) acquire antigen at sites of vaccination and migrate to draining lymph nodes, where they prime vaccine-specific T cells. The potency with which LVs activate CD8
    MeSH term(s) Animals ; Antigen Presentation ; Antigens/genetics ; Antigens/immunology ; Biomarkers ; CD11c Antigen/metabolism ; Cancer Vaccines/immunology ; Coculture Techniques ; Cross-Priming/immunology ; Dendritic Cells/immunology ; Dendritic Cells/metabolism ; Genetic Vectors/genetics ; Heparin-binding EGF-like Growth Factor/immunology ; Immunity, Cellular ; Lentivirus/genetics ; Lymph Nodes/immunology ; Lymph Nodes/metabolism ; Mice ; Models, Animal ; Neoplasms/immunology ; Neoplasms/pathology ; Neoplasms/therapy ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism ; Transduction, Genetic ; Vaccines/genetics ; Vaccines/immunology
    Chemical Substances Antigens ; Biomarkers ; CD11c Antigen ; Cancer Vaccines ; Heparin-binding EGF-like Growth Factor ; Vaccines
    Language English
    Publishing date 2017-02-02
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2010592-7
    ISSN 1525-0024 ; 1525-0016
    ISSN (online) 1525-0024
    ISSN 1525-0016
    DOI 10.1016/j.ymthe.2016.11.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top